Business · 20/06/2012
FDA Releases Draft Guidance for Implanted Blood Access Devices for Hemodialysis
The FDA has made available a draft guidance document outlining the special controls for Class II implanted blood access devices used in hemodialysis, which is not yet final or effective.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →